According to Telix Pharmaceuticals's latest financial reports the company has $84.05 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $84.05 M | 5.9% |
2022-12-31 | $79.37 M | 396.81% |
2021-12-31 | $15.97 M | -73.34% |
2020-12-31 | $59.93 M | 91.94% |
2019-12-31 | $31.22 M | 71.99% |
2018-12-31 | $18.15 M | -52.28% |
2017-12-31 | $38.04 M |